[Serum immunoglobulins in cardiovascular pathology]

Area of Science:

• Immunology
• Cardiology
• Hypertension Research

Background:

• Serum immunoglobulin levels (Immunoglobulin A, G, and M) are routinely measured.
• Cardiac and hypertensive diseases are significant global health concerns.
• Understanding immune system involvement in these conditions is crucial.

Purpose of the Study:

• To investigate serum immunoglobulin levels in patients with coronary heart disease (CHD) and hypertension.
• To compare immunoglobulin levels between healthy subjects and patients with cardiovascular conditions.
• To determine the prevalence of abnormal immunoglobulin levels in these groups.

Main Methods:

• Serum samples were collected from 100 healthy subjects, 51 CHD patients, and 50 hypertensive patients.
• Levels of Immunoglobulin A (IgA), Immunoglobulin G (IgG), and Immunoglobulin M (IgM) were measured.
• Abnormal levels were defined by established reference ranges (IgA: 100-480 mg/100ml, IgG: 500-1900 mg/100ml, IgM: 45-380 mg/100ml).

Main Results:

• Abnormal serum immunoglobulin levels were detected in 28% of patients with CHD or hypertension, versus 2% in healthy controls.
• Low immunoglobulin levels were observed in 12% of patients and 1 subject (2%) in the control group.
• High immunoglobulin levels were found in 16% of patients with CHD or hypertension.
• Abnormalities could affect any immunoglobulin class and persisted in some CHD patients for years post-event.

Conclusions:

• A significant proportion of patients with coronary heart disease or hypertension exhibit abnormal serum immunoglobulin levels.
• These immune dysregulations may be linked to the pathophysiology or progression of cardiovascular diseases.
• Further research is warranted to explore the clinical implications and potential therapeutic targets related to immunoglobulin changes in cardiac and hypertensive patients.